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Abstract
Background: Carcinoma of the recto-vaginal septum is a quite rare location and related to peritoneal and primary
ovarian carcinomas. There are only few reports in the literature with a very poor prognosis.
Case presentation: Here we report the case of a 63 years old woman with past medical history of left oophorectomy
presenting with a pelvic pain. The magnetic resonance imaging (MRI) demonstrated a 10 cm mass located in the
recto-vaginal septum. A block resection was performed allowing the retrieval of a 10 cm solid tumor of the recto-
vaginal septum. Peritoneal biopsies and the right ovary were normal the final diagnosis was cystadenocarcinoma of
the recto-vaginal septum. The patient received adjuvant chemotherapy and displays no sign of recurrence 36 months
after diagnosis.
Conclusion: The management of recto-vaginal septum carcinoma with en bloc resection should be performed to
avoid peritoneal spread and improve prognosis.
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Background
Occurrence of a carcinoma of a recto vaginal septum is
an exceptional presentation. Few cases of such disease
have been described in the literature with a poor prog-
nosis due to local early recurrence [1, 2]. While the
management of the disease is similar to an ovarian
carcinoma in particular for adjuvant treatment, the
specific prognosis of such lesion remains unknown.
Moreover surgical management of recto-vaginal septum
carcinoma can be a challenge as specific techniques
might be required to reduce the risk of peritoneal
spread of the tumor. Here we report a case of a recto
vaginal septum with emphasis on the surgical procedure,
as radicality and a bloc resection might be important
factors for local control.
Case presentation
A 63 year old patient presented to the clinic for pelvic
pain. Her past medical history included a hypothyroidy
and dyslipidemia. The BMI of the patient was normal
(BMI 19,1). Her family history was notable for an aunt
(father side) presenting with an ovarian carcinoma.
Interestingly the patient had an oophorectomy per-
formed 4 years before for a 6 cm left ovarian cyst by
laparoscopy. During the previous surgery the cyst was
adherent to the pelvic peritoneum and fallopian tube.
There was an exophytic part adhering tightly to the
rectum and Douglas Pouch. Rectal examination could
not find any rectal or recto-vaginal nodule. After adhesio-
lysis a left adnexectomy was performed without particular
difficulties. The pathology examination was consistent
with a benign serous cystadenoma of the ovary. The left
fallopian tube was normal. She underwent a CT scanner
and a colonoscopy after the surgery which with no
particular findings. She underwent regular gynecologic
examination as well as yearly pelvic ultrasound.
Four years later the pelvic ultrasound demonstrated a
retro-uterine solid 11 cm cyst. Clinical examination
found an immobile pelvic mass pushing the vagina an-
teriorly. There was no sign of vaginal or rectal invasion.
Concordantly a pelvic MRI [Figs. 1 and 2] confirmed a
10*12 cm cystic structure with thick walls. The content
of the cyst looked heterogeneous and the vegetations
within the cyst were uptaking gadolinium. There was
no sign of rectal invasion, but minimal fluid in the
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abdomen and a single external iliac node looked suspi-
cious. CA125 was above normal (112 UI/L).
A midline laparotomy was performed. On abdominal
entry the mass seemed enclaved in the recto-vaginal
septum [Fig. 3]. The right adnexa was normal. Several
enlarged lymph nodes were perceived with the bigger
located on the right iliac bifurcation. A frozen section of
this node confirmed a metastatic involvement with a
poorly differentiated carcinoma. The patient underwent
an « en bloc » resection through a retroperitoneal
dissection [Figs. 4 and 5].
She underwent a hysterectomy, right adnexectomy, a
coloprotectomy with a low colo-rectal anastomosis and
protective ileostomy, omentectomy and peritoneal biop-
sies. The vagina could be preserved. Pelvic and para-
aortic lymphadenectomy was performed. Postoperative
course was unremarkable. Pathology exam revealed an
adenocarcinoma of the recto-vaginal septum, grade 3
consistent with a serous ovarian carcinoma or a primary
peritoneal carcinoma (morphological and staining char-
acteristics). A second para-aortic node was metastatic.
The right adnexa was normal.
The patient received 6 cycles of carboplatinum and
taxol and 21 cycles of bezacizumab (AVASTIN®).
Fig. 1 Sagittal T2 weighted pelvic MRI images
Fig. 2 Sagittal T2 weighted pelvic MRI images
Fig. 3 Per-operative view of tumor located on recto-vaginal septum.
a Uterus. b Recto-vaginal septum including the tumor mass
Fig. 4 « en-bloc » resection. a Uterus. b Rectum. c Tumoral mass.
d Right ovary
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On follow-up the patient is disease free (clinical,
imaging and biological assessment) at 36 months after
diagnosis.
Discussion
Serous carcinoma of the recto-vaginal septum is an
exceptional presentation presenting multiple clinical
challenges. Extra-ovarian Primary Peritoneal Carcinoma
(EOPPC) with no ovarian lesion is a described entity [3].
It displays common traits with ovarian serous carcinomas
both on clinical presentation and pathological features
[4–6]. The main theory for the etiology of this particu-
lar disease is the presence of persisting embryologic
germinal cells (mullerian duct remnants) able to give
rise to primary peritoneal adenocarcinoma [7]. It often
presents as a serous carcinoma. A single case has been
described in a patient with previous hysterectomy and
bilateral salpingo-oophorectomy [8]. A case of recto-
vaginal serous carcinoma was reported by Leteurte et al.
[1]. The authors described the presence of tumoral foci on
the ovary without invasion suggesting a peritoneal primary
lesion of the recto-vaginal septum. In this study peritoneal
and lymph node involvement was present at diagnosis.
The patient recurred after 6 months despite aggressive
surgery and adjuvant chemotherapy. Another case of a
2.5 cm tumor was described [2] treated by radical hyster-
ectomy, bilateral salpingo-oophorectomy, lymph node
resection and adjuvant radiotherapy. The patient however
presented local and regional metastatic spread and died
30 months after diagnosis.
Among the differential diagnosis few patients had a
mesothelioma which can be easily be identified on
morphological and histological findings. These cases
are however rare.
In our case we could not differentiate between pri-
mary peritoneal versus primary ovarian tumor. How-
ever, the most likely hypothesis is the peritoneum and
recto-vaginal septum dissemination of a left ovarian
neoplasic foci resected previously. To reduce this risk,
in postmenopausic women with a solid and cystic tumor
adhered to the rectum, hysterectomy and double salpingo-
ophorectomy might be better than simple left adnexect-
omy. The treatment of primary peritoneal carcinoma is
similar to primary ovarian carcinoma with debulking sur-
gery aiming at no residual disease associated to platinium-
based chemotherapy. Our surgical approach of « en bloc »
resection seems optimal. Indeed using the retroperitoneal
sheath for all dissection leads to resection of such tumor
without entry in the tumoral mass. Preserving the integrity
of the tumor during surgery is mandatory to reduce local
dissemination, residual disease and eventually local and
distant recurrences.
Most studies report a poor prognosis for primary
peritoneal carcinoma related to extensive loco-regional
disease with an overall survival around 21 months [6, 9].
In our case, the tumor was limited to recto-vaginal wall
and there were no peritoneal lesions. This could impact
prognosis, compare to a classical ovarian cancer where the
peritoneal extension is the major factor for tumoral dis-
semination and disease recurrence.
Conclusion
Cystadenocarcinoma of the recto-vaginal septum is a
rare entity. The surgery should emphasize a retroperi-
toneal approach with an en-bloc resection to avoid as
much as possible tumor rupture. Staging and adjuvant
treatment should be performed as in primary ovarian
carcinosis. The description of more cases would lead to
a better understanding of the specificity of such location
regarding diagnosis, management and prognosis.
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Fig. 5 Recto-vaginal septum tumor
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